Analysis of Drug Impurities
A key component of the overall quality of a pharmaceutical is control of impurities, as their presence, even in small amounts, may affect drug safety and efficacy. The identification and quantification of impurities to acceptable standards presents a significant challenge to the analytical chemist. Analytical science is developing rapidly and provides increasing opportunity to identify the structure, and therefore the origin and safety implications of these impurities, and the challenges of their measurement drives the development of modern quantitative methods. Written for both practicing and student analytical chemists, Analysis of Drug Im…
Mehr
CHF 172.00
Preise inkl. MwSt. und Versandkosten (Portofrei ab CHF 40.00)
Versandkostenfrei
Produktdetails
Weitere Autoren: Smith, Richard J. (Hrsg.)
- ISBN: 978-0-470-99422-1
- EAN: 9780470994221
- Produktnummer: 13820117
- Verlag: Wiley-Blackwell
- Sprache: Englisch
- Erscheinungsjahr: 2008
- Seitenangabe: 288 S.
- Plattform: PDF
- Masse: 3'068 KB
Über den Autor
Richard Smith is Director, Analytical Sciences at GlaxoSmithKline Research and Development, Tonbridge, UK and Michael Webb is Director, Analytical Sciences at GlaxoSmithKline Research and Development, Stevenage, UK. Contributors to the book: Dr Linda Ng Dr George Lunn Dr Patrick Faustino Dr Dave Elder Dr Mark R. Hadley Dr Peter Skett Dr Gary E. Martin Dr Ian Jones Dr Janet Hammond Dr Gerald Terfloth Dr Frank Cottee
3 weitere Werke von Michael L. (Hrsg.) Webb:
Bewertungen
Anmelden